Reevaluation of lumped and rate constants is necessary when Sokoloff's 2-deoxyglucose (DO) method is used to measure glucose utilization in pathological tissue. We describe here a modification of Sokoloff's lumped constant measurement that permits simultaneous estimation of both lumped and rate constants from a single animal experiment. A subcutaneous tumor model (AA ascites tumor) was used for measurement of these constants with a procedure similar to Sokoloff's that kept the plasma tracer concentration constant. Measured con stants were as follows: lumped constant, 0.654 ± 0.081; kj, 0.196 ± 0.038 min-I; k'!J, 0.262 ± 0.067 min-I; kj, 0.117 ± 0.044 min -I. These constants were used to quan tify glucose utilization in the implanted brain tumor. To test the validity of this method, we compared a fraction
The 2-deoxyglucose (DG) method originally de veloped by Sokoloff et al. (1977) for measurement of the local cerebral metabolic rate for glucose is widely applied in animal studies employing the au toradiographic technique and in human studies em ploying positron emission tomography (P ET).
When applied to pathological tissue, this method requires reevaluation of the lumped and rate con stants that appear in the operational equation (Eq. 1, below) for quantitative measurement of the glu cose utilization rate (Sokoloff, 1979) . However, their measurement is only occasionally performed, as it requires a number of matched animals and the application of a complex mathematical operational equation on the time course of tissue and blood of the free DO pool calculated using the tumor constants with a fraction measured directly by chromatographic analysis of tissue samples from both subcutaneous tumor and implanted brain tumor. The values derived by chem ical analysis agreed well with those predicted by the cal culations. The value of k! varied from 0.0031 ± 0.0018 min-1 for the tumor tissue to 0.0214 ± 0.0024 min-1 for tumors with a large necrotic center. This method would be especially useful when applied to xenograft human gliomas in nude mice for quantification of glucose utili zation in human gliomas by means of positron emission tomography. Key Words: Deoxyglucose-GIucose utili zation-Implanted brain tumor-Lumped constant Rate constants.
tracer concentration (Sokoloff et aI., 1977; Kennedy et aI., 1978) .
In this article we describe a simplified method for the simultaneous estimation in tumor tissue of lumped and rate constants needed for quantification of the glucose utilization rate. The method requires only a single experiment for estimation of all nec essary constants. The application of this method to an experimental brain tumor is also described.
THEORY
The operational equation based on the three-com partment model of Sokoloff et al. (1977) for calcu lation of the glucose utilization rate ( R ) using DG as a tracer can be expressed as follows (Kato et aI., 1984) :
where C p is the mean plasma glucose concentration; C; (t) is the plasma tracer concentration as a func tion of time; kj, k�, and k� are the rate constants for DG; C*(t) is the cerebral tissue concentration of the tracer at a single time (n; and LC is the lumped constant. C;(t) and C*(n are measured by ra dioassay and autoradiogram, respectively. LC and kj-k� are determined by a modification of the orig inal method of Sokoloff et al. If C;(t) is maintained constant (C;) by means of a programmed infusion of the tracer (Patlak and Pettigrew, 1976) , the equa tion used for LC measurement given by Sokoloff et al. (1977) is
where C�(t) and ct(t) are the arterial and draining venous concentrations of the tracer, respectively, and Ca(t) and Cy(t) are the arterial and draining ve nous glucose concentrations, respectively.
Using an alternative expression for R derived by Phelps et al. (1979) ,
LC, q, and k� are then estimated separately;
hence,
and k� + k� ( = K) is determined from the slope of the semilogarithmic plot of the term get) minus LC as a function of time, similar to the procedure de scribed by Kennedy et al. (1978) .
After substituting R from Eq. 6, Eq. 10 can be rear ranged as follows:
After measuring tissue tracer concentration [C*(n] by sampling at the end of the experiment (t = n, kj could be calculated by Eq. 11. Constants re quired for the calculation of glucose utilization (LC, kj, k�, and kV are then estimated separately from a single experiment. The substitution of the values of these constants into Eq. 1 allows the quantifi cation of glucose utilization in the tumor. k'S for fluoro-2-deoxy glucose (FDG) was approximated with the shape of the tissue curve after 2 h when C;(t) was very low compared with C*(n and almost constant (C;). These assumptions simplify basic equations.
From the definition of the DG three-compartment model, it follows (Sokoloff et aI., 1977) that
where D f equals kj/(k� + k�), representing the dis tribution volume of the tracer. Since the term k� Df C; is constant, k'S was calculated from this linear relationship between dldt C*(t) and C*(t) after C*(t)
was approximated with a polynomial function by a least-squares method.
METHODS

Animal tumor and models
AA ascites tumor (Aptekman and Bogden, 1955) , which originally arose spontaneously in a Wistar rat, was carried by serial intramuscular transplantation in our lab oratory and transformed to a solid tumor (Arita et aI., 1983 ). An experimental brain tumor model was produced in female Wi star rats weighing 180-200 g by implanting a tumor piece (-0.3 mm in diameter) in the parietal lobe subcortically with a 30-gauge needle under aseptic con ditions (Kato et aI., 1983) . Clinical signs were monitored daily. All the animals became progressively weaker and 7 -9 days after implantation occasionally exhibited raised fur and paresis of the limbs. They died 9-15 days after tumor implantation. Median survival time was 12 days. A subcutaneous tumor model was produced by in jecting a tumor suspension under the skin of the left thigh for evaluation of the lumped and rate constants.
Miscellaneous physiological parameters (arterial blood pressure, arterial blood gas, blood sugar, and body tem perature) were monitored periodically during the tracer study, and animals with abnormal parameters (>2 SD) were omitted from this work.
Tracers
[14C]DG (specific activity 45-55 mCi/mmol) and [14C]3_ O-methylglucose (specific activity 360 mCi/mmol) were obtained from New England Nuclear (Boston, MA, U.S.A.). [18p]DG (specific activity 680 mCilmmoi) was prepared in the Montreal Neurological Institute Medical Cyclotron Unit (Diksic and Jolly, 1983) .
Measurement of lumped and rate constants
Five rats with subcutaneous tumor (6-8 days after in oculation) were used for LC and kj, k!, and kj determi nation. Tumors measured 1 x 1 x 1.5 cm, and minimal central necrosis was observed. Thigh skin adjacent to the tumor area was carefully incised. The largest draining vein from the tumor (usually a branch of the femoral vein) was cannulated with polyethylene tubing for measure ment of Cv and C� (Eq. 5). The contralateral femoral artery and vein were also cannulated for measurement of C , C�, Ca, and C: (Eq. 5) and for programmed infusion of the tracer. The animal was immobilized with a plaster cast. The infusion schedule to maintain C�(t) constant for 45 min was determined by the method of Patlak and Pet tigrew (1976) , with the input function data approximated to a sum of three exponential curves (Kato et aI., 1984) obtained from other rats with subcutaneous tumor. In fusion of the tracer was manually controlled every minute with a syringe pump (model 355; Sage Instruments), and a total of 40 f.LCi of [14C]DG was infused. Blood samples were withdrawn at increasing time intervals up to 45 min (Kato et aI., 1984) . At the end of the experiment, the animal was sacrificed and a part of the tumor was ho mogenized for radioassay of C*(n. Values of LC, kj, k!, and kj were calculated as described in Theory (above).
Substituting lumped and rate constants measured by the method described above, Eq. 1 was used for quanti fication of glucose utilization in the tumor. A significant underestimation was observed when the dephosphoryla tion rate of deoxyglucose phosphate (kn was high (Phelps et aI., 1979) . We evaluated k'S by using the subcutaneous tumor model and [18F]FDG. Since FDG behaves like DG, both chemically and biologically (Miller and Kiney, 1981) , we assumed that the magnitude of k'S for FDG would not differ significantly from that for DG.
Six rats with subcutaneous tumor were used for k'S es timation with [18F]FDG. Four were used 7 days and two 11 days after inoculation. All procedures were done under light halothane anesthesia (0.4-0.5%). The animal was fixed and shielded with lead bricks except over the sub cutaneous tumor area. Two bismuth germanate oxide gamma-ray detectors were set opposite each other in a coincidence detection mode and focused on the tumor area. After bolus injection of [18F]FDG (3 mCi), coinci dence counts were recorded every minute for 7 h.
Validation of the method
To test the validity of the constants estimated by this method, the fraction of the precursor pool [RpCn] pre dicted from the predetermined rate constants was com pared with that measured directly by chromatographic analysis in the experiment performed under the protocol of Sokoloff et al. (1977) .
The term kiA in Eq. 1 represents the precursor (free DG) pool. Rp(n is defined as
Three rats with subcutaneous tumor and three with im planted brain tumor were used. Animal preparation, [14C]DG administration, and blood sampling were per formed using a modified Sokoloff protocol (Kato et aI., 1984) . At 45 min after [14C]DG bolus injection, the animal J Cereb Blood Flow Metabol, Vol. 5, No.1, 1985 was decapitated and the tumor-bearing head or leg was immediately frozen in liquid nitrogen. Then the implanted brain tumor and contralateral gray matter or subcuta neous tumor were sampled.
Tissue samples were put into 0.5 ml of chilled 0.5 M trichloroacetic acid to stop enzymatic reactions. After addition of 1 ml of saline, the samples were homogenized for �2 min with an ultrasound tissue homogenizer (30,000 rpm). Following homogenization, the solid fraction was separated from the supernatant by centrifugation for 1 min at 12,500 g. The supernatant was transferred into liquid scintillation vials where trichloroacetic acid was extracted with 2 ml of ether. The ether layer was sepa rated and discarded, and water was evaporated to dry ness under reduced pressure in a vacuum desiccator. Fifty microliters of distilled water was added, and the samples were spotted on a preabsorbed area of Whatman LK6DF silica gel plates. Plates were developed in ethanol/ethyl acetate/water (25:5: 1). Rf values of 0.67 and 0.00 were obtained for free DG and 2-deoxY-D-glucose-6phosphate, respectively. Corresponding areas were scratched and placed into liquid scintillation vials; 200 f.LI of deionized water and 15 ml of scintillation cocktail were added, and radioactivity was measured in a liquid scin tillation counter. It was assumed that all radioactivity was present in these two fractions; however, in some samples, a small fraction with an Rf value of 0.47 was observed.
Quantification of local glucose utilization
Glucose utilization was also measured in a rat with im planted brain tumor 8 days after inoculation as an ex ample. Glucose utilization values in the brain tumor were calculated using lumped and rate constants determined in the manner described above. These values were com pared with those calculated using normal lumped and rate constants obtained in normal gray matter. Figure 1 shows an example for LC, k�, and k! measurement. In all studies, C�(t) reached a plateau level (C�) within 1 min and remained at a constant le vel during experiments (± 5%) using the pro grammed infusion technique. Curves C�, C:, q, C p ' Ca, and Cv appeared to be almost parallel, whereas ct tended to be low in the initial 10 min because of the larger extraction of [1 4 C]DG to the tissue (Fig, 1, top) . The values of k� + k! and k�/ k� were found by using a graph (Fig. 1, bottom) .
RESULTS
The calculated lumped and rate constants for five regions in the tumor tissues are given in Ta ble 1. Values previously published for normal rat (Soko loff et al., 1977) and cloned glioma (Graham et al., 1983) are also given for comparison. The values of kj and k� were similar to those of normal rat gray matter, whereas k! was twice as large as that of normal gray matter. The distribution volume of DG in the tumor was similar to that of normal gray matter. The half-life of the precursor pool was shorter in the tumor. There was a rapid buildup and then a dip at �5 min, reflecting rapid reduction of the vascular space tracer concentration. After that, tissue ac tivity increased slowly. The activity reached a pla teau at �6 h after injection and then began to de crease because of the effect of k!. C � stayed almost constant after 2 h. The value of k! for FDG obtained from the subcutaneous tumors 7 days after inocu lation was 0.0031 ± 0.0018 min-I; 11 days after inoculation it was 0.0215 ± 0.0024 min -I. Figure 3 presents a thin layer chromatogram of implanted brain tumor tissue (tumor) and contralat eral gray matter (control). The fraction of free DG [R p Cn] in the tumor was smaller than that in gray Normal rat brain data are from Sokoloff et al. (1977) . SE (normal rat brain) and SD (present study) are given in paren theses. Half-life of precursor pool = In 2/(k� + k1); distribution volume = kt/(k� + kj); glucose utilization = Cp kt kV[LC (k� + km. A mean plasma glucose concentration (Cp) value of 200 mg/dl was assumed in the calculation of the glucose utilization of normal rat brain.
matter. Values of R p (n measured with chromatog raphy as well as those calculated with the set of rate constants determined for this tumor or normal gray matter are given in Ta ble 2.
To compare the effects of lumped and rate con stants measured in the tumor with those measured in the normal rat gray matter, glucose utilization in the implanted brain tumor was calculated for both sets of constants. We evaluated six regions of in terest in the rat brain tumor (Fig. 4) . Values of glu cose utilization were calculated with different con stants (Table 3) . Thin layer chromatogram of an implanted brain tumor tissue (tumor) and the contralateral gray matter (con trol) sampled 45 min after bolus injection of [14Cldeoxy glucose (DG). Note smaller fraction of free DG in the tumor tissue.
DISCUSSION
A simplified method for the simultaneous mea surement of DG lumped and rate constants in pathological tissue, especially in tumor tissue, is de scribed here. Ree valuation of these constants in pathological tissue is important not only for accu rate measurement of glucose utilization but also for investigation of their pathophysiology, because the rate constants can reflect the true physical charac teristics of the glucose transport and metabolic ma chinery (Gjedde, 1984) . The rate constants ha ve usually been calculated by a nonlinear least-squares method applied to the time course of tissue tracer concentration obtained by sacrificing a number of matched animals at different times after infusion of a tracer. This technique introduces into the data a "noise" of biological variation that leads to uncer tainty in determination of the constants (Graham et aI., 1983) . The method describe d here enabled us to measure these constants simultaneously in a single animal, and therefore is expected to give more accurate values. Calculation 5.4 ± O.4a 6.5 ± 0.9a 13.9 ± 1.6b a Calculated with the tumor rate constants (see Table I ). b Calculated with the normal gray matter rate constants (So koloff et aI., 1977) .
J Cereb Blood Flow Metabol. Vol. 5, No.1. 1985 The main role of the rate constants in the Soko loff et ai. operational equation (1977) (Eq. 1) is to estimate the free DG fraction in the tissue [C:(1)] and subtract this from C*(1). The predicted C:(1) value in the tumor as calculated with the rate con stants measured in this work agreed well with that measured directly by tissue sampling and chroma tography. The difference of R p (Table 2 ) observed in the subcutaneous tumors and in the implanted brain tumors is attributed to the difference in C�(t), which declined faster in the subcutaneous tumor, probably owing to a larger accumulation of [1 4 C]DG in the tumor tissue. Our data suggest that use of a three-compartment model for tumor tissue is appro priate in spite of the damaged blood-brain barrier in the tumor, and that the rate constants in im planted brain tumor are not significantly different from those in subcutaneous tumor.
Among rate constants measured in the tumor, kj and k� were similar to those of normal gray matter; k!, however, was twice that of normal gray matter, suggesting higher hexokinase activity in the tumor.
k'S in the tumor tissue of rat (0.0031 ± 0.0018 min -I), though measured with [18p]PDG, was smaller than that of normal gray matter in human brain (0.0068 ± 0.0014 min -I) (Phelps et al., 1979) . According to Huang et al. (1980) , the assumption that k 4 = 0 will result in no more than a 7% under estimation of glucose utilization values. In old tu mors, however, with large necrotic centers, k'S equaled 0.0215 ± 0.0024 min -I, implying a higher activity of phosphorylase in the autolytic process.
If we assumed in our calculations that k 4 = 0 in these old tumors, the glucose utilization values would be underestimated by >40%. Except in cases such as the one mentioned above, the calculated glucose utilization values appeared to be insensitive to the set of rate constants used in this experiment. The use of normal gray matter rate constants for calculation of tumor glucose utilization changed the value by only 2%, whereas the lumped constant di rectly affected the calculation of glucose utilization (Table 3) .
The lumped constant is generally considered to be stable and characteristic of the tissue (Sokoloff et al., 1977) . Phelps et al. (1983) proposed an alter native expression for lumped constant. With anal ysis of the "stability of lumped constant," they found that a substantial change in kVk� ratios was required to cause significant changes in the lumped constant. Pardridge et al. (1982) analyzed lumped constant change theoretically, and their theory was examined in the rat brain under various plasma glu cose levels (Pettigrew et aI., 1983) . It was observed that the lumped constant was stable except in se- ([14CJDG) autoradiogram of rat brain with implanted brain tumor. Optical density of the film was converted to tissue 14C activity with an image processor (Kato et aI., 1983) . a-f, regions of interest. See Table 3 for glu cose utilization values calcu lated for these regions. vere hypoglycemic conditions where tissue glucose content could fall to zero (Lewis et aI., 1974) . The tumors studied here had a rather high blood flow, ranging from 50 to 180 mllmin/lOO g (Kato et aI., 1983) . The plasma glucose concentration of the tumor capillary is therefore considered to be close to that of an artery (normoglycemia), and the larger extraction of glucose from plasma into tumor tissue than into normal brain was expecte d not to reduce the tissue glucose content to a level low enough to affect the lumped constant value. Thus, the use of the lumped constant determined in the subcuta neous tumor model for that of the implanted brain tumor is justified.
We also estimated the regional difference of the lumped constant in implanted brain tumor. Since the lumped constant is inversely proportional to the tissue glucose content (Crane et aI., 1981) , and R" with tumor lumped constant (LCt) and tumor rate constants (ki); R" with LCt and normal gray matter rate constant (k�); Rb, with normal lumped constant (LCo) and ki; Ro' with LCo and k�. since the relationship between the tissue glucose concentration and the apparent volume of distri bution of 3-0-methylglucose is linear (Gjedde and Diemer, 1983) , the tissue concentration of 3-0methylglucose at equilibrium would display the re gional variation of the lumped constant. An auto radiogram of brain slices obtained from rats injected with 30 j,LCi of [1 4 C]3-0-methylglucose and killed after 45 min showed no apparent regional variation of 3-0-methylglucose concentration in the tumor. We therefore assumed the lumped constant in the implanted brain tumor lobe to be homogeneous and the same as that measured in the subcutaneous tumor model. By substituting these constants into Eq. 1, we were able to calculate glucose utilization in implanted brain tumors ( Fig. 4; Ta ble 3 ).
This method could be of special interest when applied to subcutaneous human gliomas trans planted into athymic mice, a xenograft model for complete quantification of human brain tumors by PET. Xenog�llft gliomas are widely used for che motherapeutic evaluation of antitumor drugs (Shapiro et aI., 1979; Schold and Bigner, 1983; Shi mura et aI., 1983) . They grow in mouse subcuta neous tissue in a manner similar to that in humans, and preserve the original histopathological charac teristics. As discussed above, the measured lumped constant in this model would be similar to that of the glioma in the human brain. Even though rate constants in the model could differ from those in the human brain, reflecting the changed environ ment around the tumor, use of the operational equa tion of Sokoloff et al. (1977) would reduce the error in the calculated glucose utilization values propa gated by rate constant inaccuracy (Sokoloff, 1979) . Since direct measurement of these constants for the human brain tumor is ethically untenable, this method, which measures lumped and rate constants simultaneously, could be immensely useful in such studies.
